FDA ANDA · ANDA211860
FOSAPREPITANT
fosaprepitant dimeglumine
Sponsor: BAXTER HLTHCARE CORP
What this page does not claim
A drug page is a reference view of public FDA data (Drugs@FDA), reproduced as published. SPEQ is not affiliated with the FDA, adds no interpretation to the record, and nothing here is medical, legal, or regulatory advice.
APPLICATION
ANDA211860
TYPE
ANDA
ORIGINAL APPROVAL
2019-09-05
LATEST ACTION
2026-10-02
ROUTE
INTRAVENOUS
DOSAGE FORM
POWDER
MARKETING STATUS
Discontinued
Products
FOSAPREPITANT DIMEGLUMINEDiscontinued
FOSAPREPITANT DIMEGLUMINE EQ 150MG BASE/VIAL · POWDER · INTRAVENOUS
Approval history
2026-10-02Labeling · Supplement 2 · standardAP
2019-09-05UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. Browse every approval SPEQ tracks →